37585-29-8 Usage
Uses
Used in Pharmaceutical Industry:
Diclofenac is used as an analgesic and anti-inflammatory agent for the treatment of various conditions characterized by pain and inflammation. It is particularly effective in managing symptoms associated with arthritis, ankylosing spondylitis, and menstrual cramps. The drug's ability to reduce prostaglandin production helps alleviate discomfort and promote healing in affected areas.
Used in Pain Management:
Diclofenac serves as a valuable pain management tool, providing relief from acute and chronic pain conditions. Its potent analgesic properties make it suitable for treating post-operative pain, dental pain, and musculoskeletal pain. The drug's effectiveness in reducing inflammation also contributes to its pain-relieving capabilities.
Used in Topical Application:
In addition to oral formulations, diclofenac is available as a topical gel, offering a non-invasive method for delivering the drug directly to the site of inflammation or injury. This mode of administration allows for targeted treatment, reducing systemic side effects and enhancing the drug's therapeutic benefits.
However, it is important to note that diclofenac carries the risk of serious cardiovascular side effects, particularly in individuals with a history of heart disease or stroke. As such, it should be used with caution and under the guidance of a healthcare professional to ensure safe and effective treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 37585-29-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,5,8 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 37585-29:
(7*3)+(6*7)+(5*5)+(4*8)+(3*5)+(2*2)+(1*9)=148
148 % 10 = 8
So 37585-29-8 is a valid CAS Registry Number.
37585-29-8Relevant academic research and scientific papers
GLYCINE B ANTAGONISTS
-
Page/Page column 45, (2010/04/27)
The invention relates to quinoline derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
HCV INHIBITORS AND METHODS OF USING THEM
-
Page/Page column 22, (2010/02/11)
The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and composit
